Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Aug;10(2):249–252. doi: 10.1128/aac.10.2.249

Dual-Action Cephalosporin Utilizing a Novel Therapeutic Principle

D Greenwood 1, F O'Grady 1
PMCID: PMC429730  PMID: 791095

Abstract

A new cephalosporin is described that overcomes, in a novel way, the general susceptibility of this group of agents to enterobacterial β-lactamases. The new compound carries a substituent that is released on cleavage of the β-lactam ring and then exhibits antibacterial activity in its own right. The possible therapeutic benefits of such an antibiotic are discussed.

Full text

PDF
249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eykyn S. Use and control of cephalosporins. J Clin Pathol. 1971 Jul;24(5):419–429. doi: 10.1136/jcp.24.5.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Greenwood D., Chan-Teoh C. H., O'Grady F. Activity of cefazolin against dense populations of enterobacteria. Antimicrob Agents Chemother. 1975 Feb;7(2):191–195. doi: 10.1128/aac.7.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Greenwood D., O'Grady F. Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies. J Infect Dis. 1973 Aug;128(2):211–222. doi: 10.1093/infdis/128.2.211. [DOI] [PubMed] [Google Scholar]
  4. Greenwood D., O'Grady F. Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. Chemotherapy. 1975;21(6):330–341. doi: 10.1159/000221878. [DOI] [PubMed] [Google Scholar]
  5. Greenwood D., O'Grady F. Resistance categories of enterobacteria to beta-lactam antibiotics. J Infect Dis. 1975 Sep;132(3):233–240. doi: 10.1093/infdis/132.3.233. [DOI] [PubMed] [Google Scholar]
  6. Greenwood D., O'Grady F. Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder. Br J Exp Pathol. 1975 Apr;56(2):167–171. [PMC free article] [PubMed] [Google Scholar]
  7. Greenwood D., O'Grady F. The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder. Br J Exp Pathol. 1974 Jun;55(3):245–250. [PMC free article] [PubMed] [Google Scholar]
  8. Mackintosh I. P., O'Grady F., Greenwood D., Watson B. W., Crichton T. C., Piper R., Ferrer A. A twelve channel bacterial growth monitoring system. Biomed Eng. 1973 Dec;8(12):514–passim. [PubMed] [Google Scholar]
  9. O'Callaghan C. H., Sykes R. B., Staniforth S. E. A new cephalosporin with a dual mode of action. Antimicrob Agents Chemother. 1976 Aug;10(2):245–248. doi: 10.1128/aac.10.2.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. O'Grady F., Mackintosh I. P., Greenwood D., Watson B. W. Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder. Br J Exp Pathol. 1973 Jun;54(3):283–290. [PMC free article] [PubMed] [Google Scholar]
  11. Steigbigel N. H., McCall C. E., Reed C. W., Finland M. Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci. 1967 Sep 27;145(2):224–236. doi: 10.1111/j.1749-6632.1967.tb50221.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES